Advertisement
Analyst Ratings

ALIZY Neutral Rating Maintained by Citi on May 15, 2026

May 16, 2026
4 min read

Key Points

Citigroup maintains Neutral rating on ALIZY, raises price target to EUR 411.70.

Allianz neutral rating reflects balanced risk-reward with modest upside potential.

Meyka AI grades ALIZY B+, citing solid fundamentals and 13.6% earnings growth.

ALIZY offers 4.43% dividend yield with reasonable P/E valuation of 13.22.

Be the first to rate this article

Citigroup kept its Neutral rating on Allianz SE (ALIZY) on May 15, 2026, signaling a steady outlook for the German insurance giant. The analyst firm raised its price target to EUR 411.70 from EUR 388, reflecting modest confidence in the company’s near-term prospects. At $43.51 per share, ALIZY trades above its 50-day average of $43.21 and 200-day average of $42.98. The Allianz neutral rating maintains analyst consensus as five of seven analysts rate the stock as Hold.

Advertisement

Citigroup Maintains Allianz Neutral Rating with Higher Price Target

Citigroup’s decision to hold its Neutral rating on Allianz reflects balanced risk-reward dynamics in the insurance sector. The analyst raised the price target to EUR 411.70 from EUR 388, suggesting upside potential of roughly 6% from current levels. This modest increase indicates Citi sees value but remains cautious about near-term catalysts.

The Allianz neutral rating aligns with broader market sentiment. Among seven analysts tracked, one rates the stock Buy, five rate it Hold, and one rates it Sell. This consensus reflects uncertainty about the company’s ability to drive earnings growth amid competitive insurance markets and rising claims costs.

Financial Metrics Show Mixed Signals for Allianz Stock

Allianz trades at a forward P/E ratio of 13.22, below the insurance sector average, suggesting reasonable valuation. The company’s return on equity stands at 17.77%, demonstrating solid profitability relative to shareholder capital. However, the dividend yield of 4.43% attracts income investors seeking stable payouts from a diversified insurer.

The company’s debt-to-equity ratio of 0.56 remains manageable for a financial services firm. With a market cap of $165.6 billion, ALIZY ranks among Europe’s largest insurers. Operating margins of 11.2% reflect the competitive nature of insurance underwriting and asset management operations.

Meyka AI Grades ALIZY with B+ Rating

Meyka AI rates ALIZY with a grade of B+, reflecting solid fundamentals and growth prospects. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The B+ rating suggests the stock offers reasonable value for investors seeking exposure to diversified insurance and asset management.

These grades are not guaranteed and we are not financial advisors. The rating incorporates forward earnings growth of 13.6% and three-year revenue growth of 85.5%, indicating Allianz is expanding faster than many mature financial services peers. Meyka’s AI-powered market analysis platform tracks real-time analyst coverage and proprietary price forecasts for 60,000+ stocks globally.

Stock Performance and Technical Outlook

ALIZY declined 1.25% on May 15, closing at $43.51 after trading between $43.37 and $43.79. Year-to-date performance shows a 5.5% decline, though the stock remains up 12.2% over the past year. The 50-day and 200-day moving averages suggest the stock is consolidating near support levels.

Technical indicators show mixed momentum. The RSI of 44.65 indicates neither overbought nor oversold conditions. The MACD histogram at -0.30 suggests weakening upside momentum, while the Stochastic oscillator at 21.88 points to potential oversold conditions. These signals align with Citi’s cautious Neutral stance on the Allianz neutral rating.

Advertisement

Final Thoughts

Citigroup’s maintained Neutral rating on Allianz reflects a balanced view of the insurance sector’s challenges and opportunities. The raised price target to EUR 411.70 signals modest upside, though the analyst remains cautious about near-term catalysts. With a B+ Meyka grade, solid dividend yield of 4.43%, and reasonable P/E valuation, ALIZY appeals to income-focused investors. However, the Allianz neutral rating suggests limited near-term momentum. Investors should monitor Q2 earnings and claims trends before making allocation decisions.

FAQs

Why did Citigroup maintain a Neutral rating on ALIZY?

Citigroup sees balanced risk-reward in Allianz. The EUR 411.70 price target reflects modest upside, but the analyst remains cautious about near-term earnings catalysts and competitive pressures.

What is the Meyka AI grade for Allianz stock?

Meyka AI rates ALIZY B+, considering sector performance, financial growth, key metrics, and analyst consensus. This suggests reasonable value for diversified insurance exposure.

What is the analyst consensus rating for ALIZY?

Among seven analysts, one rates Buy, five rate Hold, and one rates Sell. This reflects uncertainty about near-term earnings growth and competitive market dynamics.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Analyst ratings are opinions and not guarantees of future performance. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)